This creates an illusion of safety that can be more dangerous than obvious quackery
GLP-1 receptor agonists including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have produced some of the most dramatic weight loss outcomes in the history of pharmacology
This condition is characterized by an ongoing pattern of being impulsive (acting without thinking, for instance), inattentive (have trouble staying on task) or hyperactive (fidgeting excessively or seeming overly restless and talkative)
1 Department of Endocrinology, Southeast University Zhongda Hospital, Nanjing, China, 2 Pancreatic Research Institute, Southeast University School of Medicine, Nanjing, China
At the 2.4mg weekly dose, participants achieved approximately 16% mean weight loss over 68 weeks